UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

EBV-Positive and EBV-Negative Posttransplant Diffuse Large B Cell Lymphomas Have Distinct Genomic and Transcriptomic Features

American journal of transplantation, 2016-02, Vol.16 (2), p.414-425

2016

Volltextzugriff (PDF)

Molecular Pathogenesis of B-Cell Posttransplant Lymphoproliferative Disorder: What Do We Know So Far?

Clinical & developmental immunology, 2013-01, Vol.2013 (2013), p.1-13

2013

Volltextzugriff (PDF)

Primary CNS Posttransplant Lymphoproliferative Disease (PTLD): An International Report of 84 Cases in the Modern Era

American journal of transplantation, 2013-06, Vol.13 (6), p.1512-1522

2013

Volltextzugriff (PDF)

Genomewide copy number alteration screening of circulating plasma DNA: potential for the detection of incipient tumors

Annals of oncology, 2019-01, Vol.30 (1), p.85-95

2019

Volltextzugriff (PDF)

Post-transplant molecularly defined Burkitt lymphomas are frequently MYC-negative and characterized by the 11q-gain/loss pattern

Haematologica (Roma), 2015-07, Vol.100 (7), p.e275-e279

2015

Volltextzugriff (PDF)

Gene Expression Profiling Reveals Clear Differences Between EBV‐Positive and EBV‐Negative Posttransplant Lymphoproliferative Disorders

American journal of transplantation, 2013-05, Vol.13 (5), p.1305-1316

2013

Volltextzugriff (PDF)

Stromal Gene Signatures in Large-B-Cell Lymphomas

The New England journal of medicine, 2008-11, Vol.359 (22), p.2313-2323

2008

Volltextzugriff (PDF)

Myeloid-derived suppressor cells in lymphoma: The good, the bad and the ugly

Blood reviews, 2018-11, Vol.32 (6), p.490-498

2018

Volltextzugriff (PDF)

The accuracy of positron emission tomography in the detection of posttransplant lymphoproliferative disorder

Haematologica (Roma), 2013-05, Vol.98 (5), p.771-775

2013

Volltextzugriff (PDF)

Performance of advanced imaging modalities at diagnosis and treatment response evaluation of patients with post-transplant lymphoproliferative disorder: A systematic review and meta-analysis

Critical reviews in oncology/hematology, 2018-12, Vol.132, p.27-38

2018

Volltextzugriff (PDF)

Outcomes in patients with EBV+ PTLD treated with allogeneic EBV‐specific T‐cell immunotherapy (tabelecleucel) under an expanded access program (EAP) in Europe

Hematological oncology, 2023-06, Vol.41 (S2), p.523-524

2023

Volltextzugriff (PDF)

The ABC of apheresis

Acta clinica belgica (English ed. Online), 2015-04, Vol.70 (2), p.95-99

2015

Volltextzugriff (PDF)

International Prognostic Index, Type of Transplant and Response to Rituximab Are Key Parameters to Tailor Treatment in Adults With CD20‐Positive B Cell PTLD: Clues From the PTLD‐1 Trial

American journal of transplantation, 2015-04, Vol.15 (4), p.1091-1100

2015

Volltextzugriff (PDF)

Prognostic superiority of International Prognostic Index over [18F]FDG PET/CT volumetric parameters in post-transplant lymphoproliferative disorder

EJNMMI research, 2021-03, Vol.11 (1), p.29-29, Article 29

2021

Volltextzugriff (PDF)

New insights in the molecular pathogenesis of Epstein–Barr virus-positive and -negative post-transplant diffuse large B-cell lymphoma

European journal of cancer (1990), 2016-07, Vol.61, p.S189-S189

2016

Volltextzugriff (PDF)

Rituximab in auto‐immune haemolytic anaemia and immune thrombocytopenic purpura: a Belgian retrospective multicentric study

Journal of internal medicine, 2009-11, Vol.266 (5), p.484-491

2009

Volltextzugriff (PDF)

Subset characterization of myeloid-derived suppressor cells arising during induction of BM chimerism in mice

Bone marrow transplantation (Basingstoke), 2012-07, Vol.47 (7), p.985-992

2012

Volltextzugriff (PDF)

Rapid and complete hematological response of refractory hairy cell leukemia to the BRAF inhibitor dabrafenib

Annals of hematology, 2014-12, Vol.93 (12), p.2087-2089

2014

Volltextzugriff (PDF)

P1297: ABERRANT MYCN EXPRESSION DRIVES ONCOGENIC HIJACKING OF EZH2 AS A TRANSCRIPTIONAL ACTIVATOR IN PERIPHERAL T CELL LYMPHOMA

HemaSphere, 2022-06, Vol.6 (Suppl), p.1182-1183

2022

Volltextzugriff (PDF)

Semi-Quantitative Characterization of Post-Transplant Lymphoproliferative Disorder Morphological Subtypes with [ 18 F]FDG PET/CT

Journal of clinical medicine, 2021-01, Vol.10 (2), p.361

2021

Volltextzugriff (PDF)

P1339: CLINICAL OUTCOMES OF PATIENTS WITH EBV+ PTLD FOLLOWING HEMATOPOIETIC STEM CELL TRANSPLANTATION WHO FAIL RITUXIMAB: A MULTINATIONAL, RETROSPECTIVE CHART REVIEW STUDY

HemaSphere, 2022-06, Vol.6 (Suppl), p.1224-1225

2022

Volltextzugriff (PDF)

P1107: CLINICAL OUTCOMES OF SOLID ORGAN TRANSPLANT PATIENTS WITH EBV+ PTLD WHO FAIL RITUXIMAB PLUS CHEMOTHERAPY: A MULTINATIONAL, RETROSPECTIVE CHART REVIEW STUDY

HemaSphere, 2022-06, Vol.6 (Suppl), p.997-998

2022

Volltextzugriff (PDF)

3205 Obstetrical complications and neonatal outcome in patients diagnosed with acute myeloid and acute lymphoblastic leukemia during pregnancy: Results from the International Network on Cancer, Infertility and Pregnancy (INCIP) study

European journal of cancer (1990), 2015-09, Vol.51, p.S650-S650

2015

Volltextzugriff (PDF)

P1457: DEMOGRAPHICS AND TREATMENT OUTCOMES IN PATIENTS WITH EBV+ PTLD TREATED WITH OFF‐THE‐SHELF EBV‐SPECIFIC CTL (TABELECLEUCEL) UNDER AN ONGOING EXPANDED ACCESS PROGRAM IN EUROPE: FIRST ANALYSES

HemaSphere, 2022-06, Vol.6 (Suppl), p.1339-1340

2022

Volltextzugriff (PDF)

P1151: METABOLIC TUMOR VOLUME IMPROVES OUTCOME PREDICTION IN UNTREATED MANTLE CELL LYMPHOMA

HemaSphere, 2022-06, Vol.6 (Suppl), p.1038-1039

2022

Volltextzugriff (PDF)

1 – 25 von 347

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(280)
Mit Volltextzugriff
(270)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

EBV-Positive and EBV-Negative Posttransplant Diffuse Large B Cell Lymphomas Have Distinct Genomic and Transcriptomic Features

Molecular Pathogenesis of B-Cell Posttransplant Lymphoproliferative Disorder: What Do We Know So Far?

Primary CNS Posttransplant Lymphoproliferative Disease (PTLD): An International Report of 84 Cases in the Modern Era

Genomewide copy number alteration screening of circulating plasma DNA: potential for the detection of incipient tumors

Post-transplant molecularly defined Burkitt lymphomas are frequently MYC-negative and characterized by the 11q-gain/loss pattern

Gene Expression Profiling Reveals Clear Differences Between EBV‐Positive and EBV‐Negative Posttransplant Lymphoproliferative Disorders

Stromal Gene Signatures in Large-B-Cell Lymphomas

Myeloid-derived suppressor cells in lymphoma: The good, the bad and the ugly

The accuracy of positron emission tomography in the detection of posttransplant lymphoproliferative disorder

Performance of advanced imaging modalities at diagnosis and treatment response evaluation of patients with post-transplant lymphoproliferative disorder: A systematic review and meta-analysis

Outcomes in patients with EBV+ PTLD treated with allogeneic EBV‐specific T‐cell immunotherapy (tabelecleucel) under an expanded access program (EAP) in Europe

The ABC of apheresis

International Prognostic Index, Type of Transplant and Response to Rituximab Are Key Parameters to Tailor Treatment in Adults With CD20‐Positive B Cell PTLD: Clues From the PTLD‐1 Trial

Prognostic superiority of International Prognostic Index over [18F]FDG PET/CT volumetric parameters in post-transplant lymphoproliferative disorder

New insights in the molecular pathogenesis of Epstein–Barr virus-positive and -negative post-transplant diffuse large B-cell lymphoma

Rituximab in auto‐immune haemolytic anaemia and immune thrombocytopenic purpura: a Belgian retrospective multicentric study

Subset characterization of myeloid-derived suppressor cells arising during induction of BM chimerism in mice

Rapid and complete hematological response of refractory hairy cell leukemia to the BRAF inhibitor dabrafenib

P1297: ABERRANT MYCN EXPRESSION DRIVES ONCOGENIC HIJACKING OF EZH2 AS A TRANSCRIPTIONAL ACTIVATOR IN PERIPHERAL T CELL LYMPHOMA

Semi-Quantitative Characterization of Post-Transplant Lymphoproliferative Disorder Morphological Subtypes with [ 18 F]FDG PET/CT

P1339: CLINICAL OUTCOMES OF PATIENTS WITH EBV+ PTLD FOLLOWING HEMATOPOIETIC STEM CELL TRANSPLANTATION WHO FAIL RITUXIMAB: A MULTINATIONAL, RETROSPECTIVE CHART REVIEW STUDY

P1107: CLINICAL OUTCOMES OF SOLID ORGAN TRANSPLANT PATIENTS WITH EBV+ PTLD WHO FAIL RITUXIMAB PLUS CHEMOTHERAPY: A MULTINATIONAL, RETROSPECTIVE CHART REVIEW STUDY

3205 Obstetrical complications and neonatal outcome in patients diagnosed with acute myeloid and acute lymphoblastic leukemia during pregnancy: Results from the International Network on Cancer, Infertility and Pregnancy (INCIP) study

P1457: DEMOGRAPHICS AND TREATMENT OUTCOMES IN PATIENTS WITH EBV+ PTLD TREATED WITH OFF‐THE‐SHELF EBV‐SPECIFIC CTL (TABELECLEUCEL) UNDER AN ONGOING EXPANDED ACCESS PROGRAM IN EUROPE: FIRST ANALYSES

P1151: METABOLIC TUMOR VOLUME IMPROVES OUTCOME PREDICTION IN UNTREATED MANTLE CELL LYMPHOMA

Suchergebnisse filtern